6561 POSTER Updated Survival and Safety Data From RADIANT-3 – a Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Trial of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET)

✍ Scribed by Lombard-Bohas, C.; Van Cutsem, E.; Capdevila, J.; de Vries, E.G.E.; Tomassetti, P.; Lincy, J.; Winkler, R.E.; Hobday, T.; Pommier, R.; Yao, J.C.

• Book ID: 122921324
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 43 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71872-X